Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy
Anna Kron, Matthias Scheffler, Carina Heydt, Lea Ruge, Carsten Schaepers, Anna-Kristina Eisert, Sabine Merkelbach‐Bruse, Richard Riedel, Lucia Nogová, Rieke Fischer, Sebastian Michels, Diana S.Y. Abdulla, Sophia Koleczko, Jana Fassunke, Anne M. Schultheis, Florian Kron, Frank Ueckeroth, G. Weßling, Juliane Sueptitz, Frank Beckers, Jan Braess, Jens Panse, Christian Grohé, Michael W. Hamm, Hans‐Joachim Kabitz, Kato Kambartel, Britta Kaminsky, Stefan Krueger, Clemens Schulte, J. Lorenz, Johann Lorenzen, Wolfram Meister, Andreas J. Meyer, Jutta Kappes, Niels Reinmuth, Bernhard Schaaf, Wolfgang Schulte, Monika Serke, Reinhard Buettner, Jürgen Wolf
Topics & Concepts
MedicineImmunotherapyOutcome (game theory)OncologyInternal medicineCancerMathematicsMathematical economicsLung Cancer Treatments and MutationsLiver physiology and pathologyCholangiocarcinoma and Gallbladder Cancer Studies